LDLR and alkaline phosphatase measurement: To the best of our knowledge, the present study was the first to analyze the effect of genetic variants in the 3′ UTR of LDLR and the 5′ UTR of PCSK9 on response to the hypocholesterolemic effects of AP treatment.